Various lifestyle related factors are primarily responsible for the increase of
cardiovascular diseases. The development of numerous diseases such as acute
myocardial infarction, stroke and thrombosis need multiple therapies. These therapies
are based on synthetic active ingredients, which in long-term usage, give adverse side
effects. Currently, a lot of attention has been focused on nanotechnology based drug
formulation, which can provide sustained drug release, increased half-life, and in turn,
can circumvent limitations of conventional therapies. With the advent of the
nanomedical approach, the survival length of the patients can be prolonged. This
chapter mostly focuses on widely used nanomedicines in therapy and imaging of
cardiovascular diseases.
Keywords: Dendrimers, Liposomes, Micelles, Nanocarrier, Nanomedicine,
Polymeric.